| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |